Rational Adaptation of L3MBTL1 Inhibitors to Create Small-Molecule Cbx7 Antagonists

ChemMedChem- United Kingdom

doi 10.1002/cmdc.201900021

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Pharmacologic Activation of P53 by Small-Molecule MDM2 Antagonists

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2011English

Small-Molecule Inhibitors of Protein-Protein Interactions

Current Topics in Microbiology and Immunology
AllergyImmunologyMicrobiology
2011English

Small Molecule FLT3 Tyrosine Kinase Inhibitors

2012English

Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

In Silicoscreening Identified Novel Small-Molecule Antagonists of PAC1 Receptor

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2018English

Novel Small-Molecule Inhibitors of BCL-Xl to Treat Lung Cancer

Cancer Research
Cancer ResearchOncology
2013English

Identification of Small Molecule Inhibitors of Interleukin-18

Scientific Reports
Multidisciplinary
2017English

Discovery and Characterization of Small Molecule Rac1 Inhibitors

Oncotarget
Oncology
2017English

Small Molecule Inhibitors of HCV Replication From Pomegranate

Scientific Reports
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy